Skip to main content
Article thumbnail
Location of Repository

A Method for the Generation of Ectromelia Virus (ECTV) Recombinants: In Vivo Analysis of ECTV vCD30 Deletion Mutants

By Ali Alejo, Margarida Saraiva, Maria Begoña Ruiz-Argüello, Abel Viejo-Borbolla, Mar Fernández de Marco, Francisco Javier Salguero and Antonio Alcami
Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:2664468
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2006). A chemokine-binding domain in the tumor necrosis factor receptor from variola (smallpox) virus.
    2. (1997). A homolog of interleukin-10 is encoded by the poxvirus orf virus.
    3. (2004). A new member of the interleukin 10-related cytokine family encoded by a poxvirus.
    4. (2008). A Novel Role
    5. (2005). A novel role of CD30/CD30 ligand signaling in the generation of long-lived memory CD8+ T cells.
    6. (2000). A poxvirus protein that binds to and inactivates IL-18, and inhibits NK cell response.
    7. (1994). A Poxvirus Protein with a RING Zinc Finger Motif Is of Crucial Importance for Virulence. Virology 198:
    8. (1998). A poxvirus-encoded semaphorin induces cytokine production from monocytes and binds to a novel cellular semaphorin receptor,
    9. (2008). A role for NKG2D in NK cell-mediated resistance to poxvirus disease.
    10. (2003). A secreted high-affinity inhibitor of human TNF from Tanapox virus.
    11. (1992). A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection.
    12. (1998). A third distinct tumor necrosis factor receptor of orthopoxviruses.
    13. (2002). Alcami A
    14. Alcami A (2005) Secreted tumour necrosis factor inhibitors encoded by poxviruses.
    15. (2006). Anti-immunology: evasion of the host immune system by bacterial and viral pathogens.
    16. (1997). Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells and comet formation.
    17. (2002). Cloning the vaccinia virus genome as a bacterial artificial chromosome in Escherichia coli and recovery of infectious virus in mammalian cells.
    18. (1994). Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor.
    19. (2002). Cowpox virus encodes a fifth member of the tumor necrosis factor receptor family: a soluble, secreted CD30 homologue.
    20. (2006). Deciphering CD30 ligand biology and its role in humoral immunity.
    21. (1995). Ectromelia virus RING finger protein is localized in virus factories and is required for virus replication in macrophages.
    22. (2005). Ectromelia virus: the causative agent of mousepox.
    23. (2000). Engagement of CD153 (CD30 ligand) by CD30+ T cells inhibits class switch DNA recombination and antibody production in human IgD+ IgM+ B cells.
    24. (1994). Fine mechanisms of ectromelia virus thymidine kinase-negative mutants avirulence.
    25. (2005). Genome of deerpox virus.
    26. (2006). Genome of horsepox virus.
    27. (2004). Human monkeypox: an emerging zoonosis.
    28. (1993). In vitro and in vivo study of the ectromelia virus homolog of the vaccinia virus K1L host range gene.
    29. (1995). Innate resistance to lethal mousepox is genetically linked to the NK gene complex on chromosome 6 and correlates with early restriction of virus replication by cells with an NK phenotype.
    30. (2001). Insertions in the gG gene of pseudorabies virus reduce expression of the upstream Us3 protein and inhibit cell-to-cell spread of virus infection.
    31. (2006). Modulation of tumor necrosis factor by microbial pathogens.
    32. (2006). Obligatory requirement for antibody in recovery from a primary poxvirus infection.
    33. (2004). Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox.
    34. (2007). Poxviridae: The Viruses and their replication.
    35. (2003). Poxviruses and immune evasion.
    36. (2006). Properties of the recombinant TNF-binding proteins from variola, monkeypox, and cowpox viruses are different.
    37. (2006). Protective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function.
    38. (2000). Puromycin resistance (pac) gene as a selectable marker in vaccinia virus.
    39. (1996). Receptors for gamma-interferon encoded by poxviruses: implications for the unknown origin of vaccinia virus.
    40. (2008). Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA).
    41. (2008). Structure and mechanism of IFN-gamma antagonism by an orthopoxvirus IFN-gammabinding protein.
    42. (1989). Structure of vaccinia virus late promoters.
    43. (2004). Technical knockout: understanding poxvirus pathogenesis by selectively deleting viral immunomodulatory genes.
    44. (2008). The conformation of the extracellular binding domain of Death Receptor 5 in the presence and absence of the activating ligand TRAIL: a molecular dynamics study.
    45. (1985). The construction and characterization of vaccinia virus recombinants expressing foreign genes.
    46. (2008). The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccination. J Exp Med:
    47. (2004). The poxvirus p28 virulence factor is an E3 ubiquitin ligase.
    48. (2007). Three is better than one: pre-ligand receptor assembly in the regulation of TNF receptor signaling.
    49. (1990). Transient dominant selection of recombinant vaccinia viruses.
    50. (1999). Tumor necrosis factor receptors encoded by poxviruses.
    51. (1992). Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein.
    52. (1995). Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon alpha transmembrane signaling.
    53. (1995). Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity.
    54. (1999). Vaccinia virus strains Lister, USSR and Evans express soluble and cell-surface tumour necrosis factor receptors.
    55. (2006). Variation in ligand binding specificities of a novel class of poxvirus-encoded tumor necrosis factor-binding protein.
    56. (2003). Viral mimicry of cytokines, chemokines and their receptors.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.